Organization
Antares Pharma, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Antares Pharma, Inc.
... EWING, N.J., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that a Type A meeting has been scheduled ...
... of single needle. Bioject Medical Technologies Inc. Read the full report: Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), Injex Pharma AG, National Medical ...
... EWING, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that a written request for a Type A ...
... preterm birth." AMAG developed the Makena auto-injector with its device partner Antares Pharma, Inc. (NASDAQ:ATRS), which holds issued patents on the auto-injector device and drug ...
... in the class action filed on behalf of investors that purchased Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS ) securities between December 21, ...
... members with timely information, WallStEquities.com has issued free tailored Stock Review on ATRS, XRAY, IART, and BAX which is a click away athttp://www.wallstequities.com/registration. Today's attention ...
... action lawsuit has been filed on behalf of investors that purchased Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS ) securities betweenDecember 21, 2016, ...
... behalf of all persons or entities who purchased or otherwise acquired Antares Pharma, Inc. (NASDAQ:ATRS) securities between December 21, 2016 and October 12, 2017 (the ...
... Faruqi, LLP, a leading national securities law firm, reminds investors in Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ:ATRS) of the December 22, 2017 deadline ...
... & Murray LLP ("GPM") continues its investigation on behalf of Antares Pharma, Inc. ("Antares Pharma" or the "Company") (NASDAQ: ATRS ) investors concerning the Company ...
... investors that a class action lawsuit has been filed against Antares Pharma, Inc. (NASDAQ: ATRS) ("Antares" or the "Company") and other defendants, related to alleged ...
... action lawsuit has been filed on behalf of investors that purchased Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS ) securities between December 21, ...
... traders, and shareholders of Lannett Co Inc (NYSE:LCI), Oclaro, Inc. (NASDAQ:OCLR), Antares Pharma, Inc. (NASDAQ:ATRS), Workday, Inc. (NASDAQ:WDAY), The Medicines Company (NASDAQ:MDCO), and Celldex Therapeutics, ...
... the District of New Jersey on behalf of purchasers of Antares Pharma, Inc. (Nasdaq: ATRS) ("Antares" or the "Company") securities during the period between December ...
... & Murray LLP ("GPM") announces an investigation on behalf of Antares Pharma, Inc. ("Antares Pharma" or the "Company") (NASDAQ: ATRS ) investors concerning the Company ...
... the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc. ("Antares") (NASDAQ: ATRS) securities between December 21, 2016 and October 12, ...
... All persons or entities who purchased or otherwise acquired securities of Antares Pharma, Inc. ("Antares") (NASDAQ:ATRS) between December 21, 2016 and October 12, 2017. You ...
... If you want a Stock Review on XRAY, ATRS, IART, or BAX then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... LLP announces that a class action lawsuit has been filed against Antares Pharma, Inc. (Antares or the Company) (Nasdaq:ATRS) in the United States District Court ...
... EWING, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the third quarter ...
... Faruqi, LLP, a leading national securities law firm, reminds investors in Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) of the December 22, 2017 ...
... behalf of all persons or entities who purchased or otherwise acquired Antares Pharma, Inc. (NASDAQ:ATRS) securities between December 21, 2016 and October 12, 2017 (the ...
... of Howard G. Smith announces an investigation on behalf of Antares Pharma, Inc. ("Antares Pharma" or the "Company") (NASDAQ: ATRS ) investors concerning the Company ...
... latest key findings for all current investors, traders, and shareholders of Antares Pharma, Inc. (NASDAQ:ATRS), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), Hostess Brands, ...
Want to see the full history on Antares Pharma, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial